{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T12:39:32Z","timestamp":1755693572418},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,19]]},"DOI":"10.7759\/cureus.28184","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T19:12:07Z","timestamp":1660936327000},"source":"Crossref","is-referenced-by-count":2,"title":["Capecitabine-Associated Coronary Vasospasm and Cardiac Arrest"],"prefix":"10.7759","author":[{"given":"Erind","family":"Muco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haris","family":"Patail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayesha","family":"Shaik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.2.485","article-title":"Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer","volume":"17","author":"Blum JL","year":"1999","unstructured":"Blum JL, Jones SE, Buzdar AU, et al.. Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer. J Clin Oncol. 1999, 17:485-93. 10.1200\/JCO.1999.17.2.485","journal-title":"J Clin Oncol"},{"key":"ref2","article-title":"Capecitabine-induced ventricular fibrillation [Article in Dutch]","volume":"160","author":"Van Capelle AV","year":"2017","unstructured":"Van Capelle AV, de Valk J, Schakenraad D, et al.. Capecitabine-induced ventricular fibrillation [Article in Dutch]. Ned Tijdschr Geneeskd. 2017, 160:D666.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/1078155214563814","article-title":"Capecitabine-induced ventricular fibrillation arrest: possible Kounis syndrome","volume":"22","author":"Kido K","year":"2016","unstructured":"Kido K, Adams VR, Morehead RS, Flannery AH. Capecitabine-induced ventricular fibrillation arrest: possible Kounis syndrome. J Oncol Pharm Pract. 2016, 22:335-40. 10.1177\/1078155214563814","journal-title":"J Oncol Pharm Pract"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161","article-title":"Drugs that may cause or exacerbate heart failure: a scientific statement from the American Heart Association","volume":"6","author":"Page RL 2nd","year":"2016","unstructured":"Page RL 2nd, O'Bryant CL, Cheng D, et al.. Drugs that may cause or exacerbate heart failure: a scientific statement from the American Heart Association. Circulation. 2016, 6:261. 10.1161","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccl.2019.07.004","article-title":"Fluoropyrimidine-associated cardiotoxicity","volume":"37","author":"Kanduri J","year":"2019","unstructured":"Kanduri J, More LA, Godishala A, Asnani A. Fluoropyrimidine-associated cardiotoxicity. Cardiol Clin. 2019, 37:399-405. 10.1016\/j.ccl.2019.07.004","journal-title":"Cardiol Clin"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.11.1795","article-title":"Cardiotoxicity of high-dose continuous infusion fluorouracil: a prospective clinical study","volume":"10","author":"de Forni M","year":"1992","unstructured":"de Forni M, Malet-Martino MC, Jaillais P, et al.. Cardiotoxicity of high-dose continuous infusion fluorouracil: a prospective clinical study. J Clin Oncol. 1992, 10:1795-801. 10.1200\/JCO.1992.10.11.1795","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1159\/000072334","article-title":"High incidence of angina pectoris in patients treated with 5-fluorouracil. A planned surveillance study with 102 patients","volume":"65","author":"Wacker A","year":"2003","unstructured":"Wacker A, Lersch C, Scherpinski U, Reindl L, Seyfarth M. High incidence of angina pectoris in patients treated with 5-fluorouracil. A planned surveillance study with 102 patients. Oncology. 2003, 65:108-12. 10.1159\/000072334","journal-title":"Oncology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199957040-00003","article-title":"Cardiotoxicity of the antiproliferative compound fluorouracil","volume":"57","author":"Becker K","year":"1999","unstructured":"Becker K, Erckenbrecht JF, H\u00e4ussinger D, Frieling T. Cardiotoxicity of the antiproliferative compound fluorouracil. Drugs. 1999, 57:475-84. 10.2165\/00003495-199957040-00003","journal-title":"Drugs"},{"key":"ref9","article-title":"Delayed coronary vasospasm in a patient with metastatic gastric cancer receiving FOLFOX therapy","volume":"38","author":"Little CJ","year":"2021","unstructured":"Little CJ, Nguyen BS, Tsing PJ. Delayed coronary vasospasm in a patient with metastatic gastric cancer receiving FOLFOX therapy. Fed Pract. 2021, 38:S76-80.","journal-title":"Fed Pract"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/107988-capecitabine-associated-coronary-vasospasm-and-cardiac-arrest","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:38:33Z","timestamp":1707507513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/107988-capecitabine-associated-coronary-vasospasm-and-cardiac-arrest"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.28184","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,19]]}}}